Navigation Links
Pediatric Dengue Vaccine Initiative and Hawaii Biotech Partner Against Dengue Fever

The Pediatric Dengue Vaccine Initiative (PDVI), a program of the International Vaccine Institute (IVI), and Hawaii Biotech // , announced today their partnership to help develop and make a Dengue vaccine widely available for the global prevention of Dengue fever, the second most widespread tropical disease after malaria.

Dengue fever is a mosquito-borne disease to which over 2 billion people are exposed and which leads to infection in up to 100 million people every year, primarily children. Dengue infection results in about 20,000 deaths from dengue hemorrhagic fever and dengue shock syndrome, the most severe forms of the disease, according to estimates from the World Health Organization (WHO)*.

"Our primary objective is to ensure rapid introduction of Dengue vaccines into immunization programs in all affected areas as soon as a vaccine becomes available. Working with Hawaii Biotech puts us in collaboration with one of the leading companies concerned with this important disease” said Harold Margolis, Director of the PDVI. "

Dengue is a mosquito transmitted disease and occurs mostly in urban areas of Latin American and Asia with an unknown level in Africa. The disease causes substantial illness and significant economic costs for hospitalizations and treatment. Efforts to control the mosquitoes are expensive, of varying success, and difficult to sustain.

The IVI, based in Seoul, Korea, is the world’s only International Organization solely dedicated to vaccine research and development.

“The IVI has grown rapidly in its short life and we are enthusiastic about this close association with Hawaii Biotech. We believe this partnership will greatly accelerate our work to reduce the burden of dengue in developing countries” said Dr. John Clemens, Director General of IVI.

Hawaii Biotech has a long involvement in development of dengue vaccines and is the only company pursuing a novel approach that relies on p roduction of virus components through genetic technologies. Vaccines made with this modern technology are known for being very safe and effective.

“Hawaii Biotech’s state-of-the-art vaccine protein manufacturing process is ideal to address emerging and re-emerging infectious diseases at their origin in developing countries. We’re delighted to enter into this partnership with PDVI, and appreciate their recognition of our R&D program’s excellence and promise”, commented Leonard Firestone, MD, President and Chief Executive Officer.

Source-Newswis
SRM
'"/>




Related medicine news :

1. Support Services found to Dramatically Impact Pediatric Health Care
2. Pediatricians differ in their opinion of child abuse
3. New Treatment Discovered For Pediatric Cholera
4. Pediatricians Need To Talk To Parents Of Overweight Kids
5. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
6. FDA Accords Priority Review For Pediatric Crohns Disease Drug
7. WHO Updates Outdated Pediatric Growth Charts
8. Pediatricians Resignations Cause Concern at Sale
9. Mental Health Providers Can Be Successfully Located With Pediatricians
10. World’s First Pediatric Laparoscopic Liver Surger
11. Pediatric Dental Care Found Wanting
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology: